IQInvest
Sign in

ZTS

Zoetis Inc.

NYQ · Healthcare

$76.44

-$0.73 (-0.95%)down -0.95%

25 August 2026 · delayed 15+ min

F

Quality score57.5 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Zoetis Inc. earns a F on excellent profit margins (>20%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and negative revenue growth. Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · $400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-ZTS-20260825engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

$71.00

Today's price

$76.44

Lowest analyst target

$80.00

Mean analyst target

$100.62

52-week high

$156.49

Highest analyst target

$160.00

ZTS trades 6% of the way up its 52-week range, between $71.00 and $156.49. The mean analyst target of $100.62 is 31.6% above today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Strong ROE (>20%); High debt-to-equity ratio (>2.0); Negative revenue growth 95.023%

Profit margin

27.68%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

40.72%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

71.74%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

64.91%

Profit per unit of shareholder capital

very strongWhat this means

Profit generated per unit of shareholder capital.

Rare when sustained — check whether debt is flattering it, since borrowing shrinks the equity denominator.

Return on assets

15.35%

Profit per unit of assets

very strongWhat this means

Profit generated per unit of everything the company owns.

Usually an asset-light business — the value is in people and brands, not property.

Debt to equity

294.00

Borrowings against equity

heavily gearedWhat this means

Borrowings measured against shareholder capital.

Debt magnifies both good years and bad, and raises the stakes when rates rise.

Current ratio

3.08

Short-term assets over short-term debts

very liquidWhat this means

Short-term assets against short-term obligations.

Plenty of cover, though idle cash earns little.

Quick ratio

1.57

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

-0.20%

Year on year

shrinkingWhat this means

Change in revenue against the same period last year.

Revenue is falling, which puts every margin under pressure.

Earnings growth

1.20%

Year on year

modestWhat this means

Change in earnings against the same period last year.

Slow profit growth.

Revenue

$4.73B

Trailing twelve months

Free cash flow

$2.02B

Cash left after capital spending

Operating cash flow

$2.84B

Cash from the business itself

Payout ratio

33.61%

Dividends as a share of earnings

conservativeWhat this means

The share of earnings paid out as dividends.

Comfortably covered, with room to keep raising it.

Growth & momentumPoor 1-year return (-49.8%); Low Sharpe ratio (-0.55) 0.022%

Return, 1 month

-1.38%

Return, 3 months

-3.15%

Return, 6 months

-40.05%

Return, year to date

-38.34%

Return, 1 year

-49.80%

Return, 3 years

-55.95%

Sharpe ratio

-0.55

Return earned per unit of risk

negativeWhat this means

Return earned per unit of risk taken.

The risk taken has not been rewarded over this period.

Win rate

49.36%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

-0.06%

Best day

7.09%

Worst day

-21.50%

ValuationAttractive P/E ratio (12.6); High PEG ratio (6.97); High P/B ratio (9.75) 55.018%

P/E ratio

12.55

Price against trailing earnings

moderateWhat this means

You pay 12.55 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

11.58

Price against forecast earnings

lowWhat this means

Price against next year's *forecast* earnings.

The market expects little growth, or doubts the forecast.

PEG ratio

6.97

P/E adjusted for growth

expensive for the growthWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Above 2 you pay more per unit of growth than the convention treats as reasonable.

Price to book

9.75

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

3.32

Price against revenue

moderateWhat this means

Price against revenue — usable when a company has no profit yet.

A common range for a profitable, growing business.

EV / EBITDA

9.71

Whole-company value against cash earnings

moderateWhat this means

Whole-company value, debt included, against cash earnings.

A conventional range.

Enterprise value

$39.47B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

413,223,602

Shares the profit is split across

Dividend yield

2.75%

Annual dividend against price

meaningfulWhat this means

Annual dividend as a percentage of the share price.

A substantial part of the total return arrives as income.

TechnicalRSI in healthy range (30-70); MACD bullish (positive histogram); Price well below 200-day SMA (downtrend) 80.015%

RSI (14)

51.7

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

0.04

Momentum against its own trend

MACD histogram

0.32

Positive is bullish

ADX

11.2

Trend strength; above 25 is a real trend

no clear trendWhat this means

Trend strength, regardless of direction.

Below about 20 the price is ranging rather than trending.

20-day average

$75.60

50-day average

$75.55

200-day average

$103.71

Price vs 50-day

1.18%

Price vs 200-day

-26.29%

Bollinger upper

$78.79

Bollinger lower

$72.41

Average true range

2.74

Typical daily trading range

Stochastic %K

63.3

RiskHigh drawdown risk 35.012%

Volatility, annualised

29.41%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.73

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-69.48%

Worst peak-to-trough fall

severeWhat this means

The worst peak-to-trough fall in the period measured.

A fall this deep needs roughly a doubling to recover.

Risk category

High

The engine's own banding

Analyst viewAnalyst consensus: Buy; Significant upside potential (31.6%) 95.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

16

Mean price target

$100.62

Highest target

$160.00

Lowest target

$80.00

Implied upside

31.64%

Target against today's price

largeWhat this means

How far the mean analyst target sits above today's price.

A wide gap, which as often means the price has fallen as that the target is right.

Price against the S&P 500

180 trading days to 2026-08-25

ZTS is 34.6% down over the window, against 11.6% up for the S&P 500 — behind by 46.1 points.
ZTS -34.6%S&P 500 +11.6%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2025-12-05, so they can be compared directly.
DateCloseZTS rebasedS&P 500 rebased
2025-12-05$116.82100.0100.0
2025-12-29$124.04106.2100.5
2026-01-21$123.68105.9100.1
2026-02-11$127.23108.9101.0
2026-03-05$120.86103.599.4
2026-03-26$115.3298.794.3
2026-04-17$121.01103.6103.7
2026-05-08$82.2670.4107.7
2026-06-01$77.0265.9110.6
2026-06-23$76.3165.3107.2
2026-07-15$74.0163.4110.2
2026-08-05$74.3963.7112.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health95.023%21.9
Growth & momentum0.022%0.0
Valuation55.018%9.9
Technical80.015%12.0
Risk35.012%4.2
Analyst view95.010%9.5
ESG50.00%0.0
Quality score100%57.5

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

57.5 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Worst dayGrowth & momentum-21.50%Yahoo Finance
Win rateGrowth & momentum49.36%Yahoo Finance
VolumeMarket data977,282Yahoo Finance
Volatility, annualisedRisk29.41%Yahoo Finance
Stochastic %KTechnical63.3Yahoo Finance
Sharpe ratioGrowth & momentum-0.55Yahoo Finance
Shares outstandingValuation413,223,602Yahoo Finance
RSI (14)Technical51.7Yahoo Finance
Risk categoryRiskHighYahoo Finance
Revenue growthFinancial health-0.20%Yahoo Finance
RevenueFinancial health$4.73BYahoo Finance
Return, year to dateGrowth & momentum-38.34%Yahoo Finance
Return, 6 monthsGrowth & momentum-40.05%Yahoo Finance
Return, 3 yearsGrowth & momentum-55.95%Yahoo Finance
Return, 3 monthsGrowth & momentum-3.15%Yahoo Finance
Return, 1 yearGrowth & momentum-49.80%Yahoo Finance
Return, 1 monthGrowth & momentum-1.38%Yahoo Finance
Return on equityFinancial health64.91%Yahoo Finance
Return on assetsFinancial health15.35%Yahoo Finance
Quick ratioFinancial health1.57Yahoo Finance
Profit marginFinancial health27.68%Yahoo Finance
Price vs 50-dayTechnical1.18%Yahoo Finance
Price vs 200-dayTechnical-26.29%Yahoo Finance
Price to salesValuation3.32Yahoo Finance
Price to bookValuation9.75Yahoo Finance
Previous closeMarket data$77.17Yahoo Finance
PEG ratioValuation6.97Yahoo Finance
Payout ratioFinancial health33.61%Yahoo Finance
P/E ratioValuation12.55Yahoo Finance
Operating marginFinancial health40.72%Yahoo Finance
Operating cash flowFinancial health$2.84BYahoo Finance
OpenMarket data$76.65Yahoo Finance
Mean price targetAnalyst view$100.62Yahoo Finance
Maximum drawdownRisk-69.48%Yahoo Finance
MACD histogramTechnical0.32Yahoo Finance
MACDTechnical0.04Yahoo Finance
Lowest targetAnalyst view$80.00Yahoo Finance
Implied upsideAnalyst view31.64%Yahoo Finance
Highest targetAnalyst view$160.00Yahoo Finance
Gross marginFinancial health71.74%Yahoo Finance
Free cash flowFinancial health$2.02BYahoo Finance
Forward P/EValuation11.58Yahoo Finance
EV / EBITDAValuation9.71Yahoo Finance
Enterprise valueValuation$39.47BYahoo Finance
EmployeesMarket data14,500Yahoo Finance
Earnings growthFinancial health1.20%Yahoo Finance
Dividend yieldValuation2.75%Yahoo Finance
Debt to equityFinancial health294.00Yahoo Finance
Day lowMarket data$75.88Yahoo Finance
Day highMarket data$77.35Yahoo Finance
Current ratioFinancial health3.08Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Bollinger upperTechnical$78.79Yahoo Finance
Bollinger lowerTechnical$72.41Yahoo Finance
BetaRisk0.73Yahoo Finance
Best dayGrowth & momentum7.09%Yahoo Finance
Average volumeMarket data6,704,533Yahoo Finance
Average true rangeTechnical2.74Yahoo Finance
Average daily returnGrowth & momentum-0.06%Yahoo Finance
Analysts coveringAnalyst view16Yahoo Finance
ADXTechnical11.2Yahoo Finance
52-week lowMarket data$71.00Yahoo Finance
52-week highMarket data$156.49Yahoo Finance
50-day averageTechnical$75.55Yahoo Finance
200-day averageTechnical$103.71Yahoo Finance
20-day averageTechnical$75.60Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more